Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Neurodegenerative Disease Management|December 5, 2015
IFN-γ for Friedreich ataxia: present evidenceMcKenzie Wells, Lauren Seyer, Kimberly Schadt, et al.Seminars in Pediatric Neurology|May 9, 2018
Pediatric Ataxia: Focus on Chronic DisordersDavid R Lynch, Ashley McCormick, Kimberly Schadt, et al.Annals of Clinical and Translational Neurology|April 26, 2019
Identification of a novel missense mutation in Friedreich's ataxia -FXNW 168RElisia Clark, Cassandra Strawser, Kimberly Schadt, et al.BMC Neurology|January 13, 2016
Friedreich Ataxia and nephrotic syndrome: a series of two patientsJulianna E Shinnick, Charles J Isaacs, Sharon Vivaldi, et al.Muscle & Nerve|June 18, 2019
Open-label pilot study of oral methylprednisolone for the treatment of patients with friedreich ataxiaMaya Patel, Kimberly Schadt, Ashley McCormick, et al.Neurology and Therapy|April 30, 2025
Safety Monitoring of Omaveloxolone in Friedreich Ataxia: Results from One Year of Clinical TreatmentKatherine Gunther, Victoria Profeta, Medina Keita, et al.Expert Review of Neurotherapeutics|July 21, 2017
Pharmacological therapeutics in Friedreich ataxia: the present stateCassandra Strawser, Kimberly Schadt, Lauren Hauser, et al.Journal of the Neurological Sciences|May 17, 2024
Characterization of clinical serum cardiac biomarker levels in individuals with Friedreich ataxiaDavid R Lynch, Sonal Sharma, Patrick Hearle, et al.Journal of Child Neurology|April 14, 2016
Comorbid Medical Conditions in Friedreich Ataxia: Association With Inflammatory Bowel Disease and Growth Hormone DeficiencyJulianna E Shinnick, Kimberly Schadt, Cassandra Strawser, et al.Annals of Clinical and Translational Neurology|September 21, 2016
Progression of Friedreich ataxia: quantitative characterization over 5 yearsMaya Patel, Charles J Isaacs, Lauren Seyer, et al.Pageof 1